In-shoe sensors, AI and biomarkers will monitor muscular dystrophy and atrophy in children, adolescents and adults — with ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Exercise has been shown to improve brain health and reduce the risk of cognitive decline and dementia over the long-term. But ...

In September, presented data on the long-term safety of ampreloxetine in nOH at the 2024 International Congress of Parkinson's Disease and Movement Disorders ®. Data indicate ampreloxetine was ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...